News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Interleukin Genetics Inc. (ILGN) Achieves Milestone And Receives $2 Million Pre-payment


10/19/2005 5:11:02 PM

WALTHAM, Mass.--(BUSINESS WIRE)--April 25, 2005--Interleukin Genetics, Inc. (OTCBB: ILGN) reported today that it has received its Clinical Laboratory Improvement Amendments (CLIA) certificate of registration for its DNA clinical laboratory. As a result of this event, Interleukin has received a $2 million pre-payment for genetic tests to be processed by the company pursuant to its Distribution Agreement with Access Business Group International, an affiliate of Alticor.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES